These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35075598)

  • 1. Clinical and radiographic effectiveness of mineral trioxide aggregate (MTA) partial pulpotomy with low power or high power diode laser irradiation in deciduous molars: a randomized clinical trial.
    Ebrahimi M; Changiz S; Makarem A; Ahrari F
    Lasers Med Sci; 2022 Jun; 37(4):2293-2303. PubMed ID: 35075598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy.
    Saltzman B; Sigal M; Clokie C; Rukavina J; Titley K; Kulkarni GV
    Int J Paediatr Dent; 2005 Nov; 15(6):437-47. PubMed ID: 16238654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial.
    Cuadros-Fernández C; Lorente Rodríguez AI; Sáez-Martínez S; García-Binimelis J; About I; Mercadé M
    Clin Oral Investig; 2016 Sep; 20(7):1639-45. PubMed ID: 26578117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparison of calcium hydroxide + biostimulation, calcium hydroxide, formocresol, and MTA pulpotomies without biostimulation in primary teeth: 12-months clinical and radiographic follow-up.
    Kaya C; Elbay ÜŞ; Elbay M; Uçar G
    Lasers Med Sci; 2022 Jul; 37(5):2545-2554. PubMed ID: 35230575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between calcium hydroxide mixtures and mineral trioxide aggregate in primary teeth pulpotomy: a randomized controlled trial.
    Silva LLCE; Cosme-Silva L; Sakai VT; Lopes CS; Silveira APPD; Moretti Neto RT; Gomes-Filho JE; Oliveira TM; Moretti ABDS
    J Appl Oral Sci; 2019 May; 27():e20180030. PubMed ID: 31116277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report.
    Eidelman E; Holan G; Fuks AB
    Pediatr Dent; 2001; 23(1):15-8. PubMed ID: 11242724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radiographic study.
    Olatosi OO; Sote EO; Orenuga OO
    Niger J Clin Pract; 2015; 18(2):292-6. PubMed ID: 25666010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth.
    Srinivasan D; Jayanthi M
    Indian J Dent Res; 2011; 22(3):385-90. PubMed ID: 22048576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study.
    Erdem AP; Guven Y; Balli B; Ilhan B; Sepet E; Ulukapi I; Aktoren O
    Pediatr Dent; 2011; 33(2):165-70. PubMed ID: 21703067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study of Mineral Trioxide Aggregate in primary molars. Comparison between Grey and White MTA--a long term follow-up (84 months).
    Cardoso-Silva C; Barbería E; Maroto M; García-Godoy F
    J Dent; 2011 Feb; 39(2):187-93. PubMed ID: 21144878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTA and ferric sulfate in pulpotomy outcomes of primary molars: a systematic review and meta-analysis.
    Asgary S; Shirvani A; Fazlyab M
    J Clin Pediatr Dent; 2014; 39(1):1-8. PubMed ID: 25631717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars.
    Noorollahian H
    Br Dent J; 2008 Jun; 204(11):E20. PubMed ID: 18425074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and radiographic comparison of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in primary molars.
    Patidar S; Kalra N; Khatri A; Tyagi R
    J Indian Soc Pedod Prev Dent; 2017; 35(4):367-373. PubMed ID: 28914251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial pulpotomy success in primary molars followed up for 24 months: A randomized controlled clinical trial using mineral trioxide aggregate, biodentine, and acemannan.
    Tungjitphianpong P; Trairatvorakul C; Thunyakitpisal P; Songsiripradubboon S
    Int J Paediatr Dent; 2024 Sep; 34(5):630-638. PubMed ID: 38297465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineral trioxide aggregate versus calcium hydroxide for pulpotomy in primary molars.
    Liu H; Zhou Q; Qin M
    Chin J Dent Res; 2011; 14(2):121-5. PubMed ID: 22319753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinical and Radiographic Success of Primary Molar Pulpotomy Using Biodentine™ and Mineral Trioxide Aggregate: A 24-Month Randomized Clinical Trial.
    Bani M; Aktaş N; Çınar Ç; Odabaş ME
    Pediatr Dent; 2017 Jul; 39(4):284-288. PubMed ID: 29122067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy.
    Doyle TL; Casas MJ; Kenny DJ; Judd PL
    Pediatr Dent; 2010; 32(1):41-7. PubMed ID: 20298652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2-year follow-up.
    Ansari G; Ranjpour M
    Int Endod J; 2010 May; 43(5):413-8. PubMed ID: 20518934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Glenny AM; Courson F; Durieux P; Muller-Bolla M; Fron Chabouis H
    Cochrane Database Syst Rev; 2018 May; 5(5):CD003220. PubMed ID: 29852056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth.
    Çelik BN; Mutluay MS; Arıkan V; Sarı Ş
    Clin Oral Investig; 2019 Feb; 23(2):661-666. PubMed ID: 29744721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.